• Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (PubMed=2233717; PubMed=2253237).
  

PubMed=3297309
Bogenmann E., Moghadam H., DeClerck Y.A., Mock A.F.
c-myc amplification and expression in newly established human osteosarcoma cell lines.
Cancer Res. 47:3808-3814(1987)

PubMed=2233717; DOI=10.1128/mcb.10.11.5772-5781.1990; PMCID=PMC361354
Diller L., Kassel J., Nelson C.E., Gryka M.A., Litwak G., Gebhardt M., Bressac B., Ozturk M., Baker S.J., Vogelstein B., Friend S.H.
p53 functions as a cell cycle control protein in osteosarcomas.
Mol. Cell. Biol. 10:5772-5781(1990)

PubMed=2253237
Miller C.W., Aslo A., Tsay C., Slamon D.J., Ishizaki K., Toguchida J., Yamamuro T., Lampkin B.C., Koeffler H.P.
Frequency and structure of p53 rearrangements in human osteosarcoma.
Cancer Res. 50:7950-7954(1990)

PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005; PMCID=PMC5501076
Li J., Zhao W., Akbani R., Liu W.-B., Ju Z.-L., Ling S.-Y., Vellano C.P., Roebuck P., Yu Q.-H., Eterovic A.K., Byers L.A., Davies M.A., Deng W.-L., Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D., Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y.-L., Mills G.B., Liang H.
Characterization of human cancer cell lines by reverse-phase protein arrays.
Cancer Cell 31:225-239(2017)